The HIFU treatment for prostate cancer is a cutting-edge, non-invasive ultrasound procedure with low risk of side effects. This advanced treatment is being offered at Central Ohio Urology Group by Dr. Rush Patel.
A 2018 study published by European Association of Urology reported five-year HIFU results that showed a 98% metastasis-free survival rate, with 98% of the patients maintaining urinary continence similar to pre-treatment. Dr. Patel offers a variety of prostate cancer treatments, but HIFU allows him to use recent advancements in diagnostic imaging to customize each HIFU treatment to the patient.
